Endocrinology - Alison's Flashcards
Define diabetes mellitus.
Syndrome of chronic hyperglycaemia due to relative insulin deficiency, resistance or both
Consequences of hyperglycaemia?
Hyperglycaemia results in serious microvascular (retinopathy, nephropathy, neuropathy) or macrovascular (strokes, renovascular disease, limb ischaemia and above all heart disease) problems
What are optimum levels of blood glucose?
Blood glucose levels should be between 3.5-8.0mmol/L under all conditions
Explain the role of the liver in glucose homeostasis?
- Stores & absorbs glucose as glycogen
- Performs gluconeogenesis from fat, protein & glycogen
- If BG HIGH = produce glycogen = glycogenesis - long term makes triglycerides (lipogenesis)
- If BG LOW = glycogen splitting into glucose = glycogenolysis.. long term makes glucose from amino acids/lactate (gluconeogenesis
How much glucose is produced and used per day?
~200g
Where is glucosed derived?
90% = liver glycogen & hepatic gluconeogenesis 10% = renal gluconeogenesis
Why is the brain the major glucose consumer?
- The brain cannot use free FAs to be converted to ketones which can be converted into Acetyl-CoA and used in Kreb’s as free FAs CANNOT CROSS BLOOD BRAIN BARRIER
- Brain glucose uptake is OBLIGATORY and not insulin dependant. Glucose is oxidised to CO2 & H2O
Where are insulin-responsive glucose transporters and their effect?
Muscle and fat
Absorb glucose in response to postprandial (post-meal) peaks in glucose and insulin
What happens to glucose taken up by muscle?
Stored as glycogen or metabolised to lactate or CO2 and H2O
What does fat use glucose for?
Triglyceride synthesis
Explain the process of lipolysis?
Lipolysis of triglyceride releases fatty acids + glycerol - the glycerol is then used as a substrate for hepatic gluconeogeneis
Describe the action of insulin?
-Suppresses hepatic glucose output - decreases glycogenolysis & gluconeogenesis
- Increases glucose uptake into insulin sensitive tissues:
Muscle - glycogen & protein synthesis
Fat - fatty acid synthesis
Suppresses:
Lipolysis
Breakdown of muscles (decreased ketogenesis)
Explain biphasic insulin release?
Biphasic insulin release:
B-cells can sense the rising glucose levels and aim to metabolise it by releasing insulin - glucose levels are the major controlling factor in insulin release
First phase response is the RAPID RELEASE of stored insulin
If glucose levels remain high then the second phase is initiated, this takes longer than the first phase due to the fact that more insulin must be synthesised
Describe the action of glucagon?
-Increases hepatic glucose output - increases glycogenolysis & gluconeogenesis
-Reduces peripheral glucose uptake
-Stimulates peripheral release of gluconeogenic precursors e.g. glycerol & amino acids
Stimulates:
Lipolysis
Muscle glycogenolysis & breakdown (increased ketogenesis)
What are the other counter-regulatory hormones to glucagon?
- Adrenaline, Cortisol and Growth Hormone
- These increase glucose production in the liver and reduce its utilisation in fat and muscle
Where is insulin coded for?
Chromosome 11
Where is insulin produced?
Beta cells on the islets of langerhans of the pancreas
Explain how insulin is cleaved from proinsulin?
- Proinsulin is the precursor of insulin
- It contains the Alpha & Beta chains of insulin which are joined together by a C PEPTIDE
- When insulin is being produced, the proinsulin is cleaved from its C peptide and is then used to make insulin which is then packaged into insulin secretory granules
- Thus when there is insulin release there will also be a high level of C peptide in the blood from the cleavage of the proinsulin from it
- Synthetic insulin DOES NOT have C peptide - thus the presence of C peptide in the blood determines whether release is natural (then C peptide will be present) or synthetic (then C peptide will not be present)
How much insulin is extracted and degraded in the liver?
~50%
How does glucose get across membranes?
Cell membranes are not inherently permeable to glucose
A family of specialised glucose-transporter (GLUT) proteins carry glucose through the membrane and into cells
What do GLUT1 receptors do?
Enables basal NON-INSULIN-STIMULATED glucose uptake into many cells
What do GLUT2 receptors do?
- Found in BETA-CELLS of the pancreas
- Transports glucose into the beta-cell - enables these cells the SENSE GLUCOSE LEVELS
- Is a low affinity transporter that is, it only allows glucose in when there is a high concentration of glucose i.e. when glucose levels are high and thus WANT insulin release
- In this way via GLUT2 beta-cells are able to detect high glucose levels and thus release INSULIN in response
- Also found in the renal tubules and hepatocytes
What do GLUT3 receptors do?
Enables NON-INSULIN-MEDIATED glucose uptake into BRAIN NEURONES & PLACENTA
What do GLUT4 receptors do?
Mediates much of the PERIPHERAL ACTION of INSULIN
It is the channel through which glucose is taken up into MUSCLE and ADIPOSE TISSUE cells following stimulation of the insulin receptor by INSULIN binding to it
What is an insulin receptor and what is it’s role?
A glycoprotein, coded for on the short arm of chromosome 19, which straddles the cell membranes of many cells
-insulin binds = activation of tyrosine kinase and initiation of a cascade response = migration of the GLUT-4 transporter to the cell surface and increased transport of glucose into the cell
What are causes of secondary diabetes?
-Pancreatic pathology e.g. total pancreatectomy, chronic pancreatitis, haemochromatosis
-Endocrine disease e.g. acromegaly and Cushing’s disease
-Drug induced
-Maturity onset diabetes of youth (MODY):
Autosomal dominant form of type 2 diabetes - single gene defect altering beta cell function
Tends to present <25 yrs with a positive family history
What drugs can cause secondary diabetes?
- Thiazide diuretics
- Beta-blockers
- Immunosuppressives e.g. ciclosporin and tacrolimus (used in UC and skin)
- Thyroid hormone
- Corticosteroids
What are the most common causes of premature death in diabetes patients?
Cardiovascular problems - 70%
Chronic kidney disease - 10%
Infections - 6%
Directly related to hyperglycaemia
What are macrovascular complications of diabetes?
- Atherosclerosis - so more likley to have stroke, ischaemic heart disease, peripheral vascular disease etc
- Peripheral vascular disease - Affects distal vessels. 15-40 times more likely to have lower limb amputation. Symptoms include intermittent claudication and rest pain
What are the microvascular complications of diabetes?
- Retinopathy
- Nephropathy
- Neuropathy
Manifest 10-20 years after diagnosis in young patients
What is diabetic retinopathy?
- Microaneurysms (seen as tiny red dots) form due to poorly controlled diabetes causing intramural pericyte death and thickening of the basement membrane.
- Haemorrhages (seen as blots) form due to breach of the microaneurysms causing leakage of fluid into the retina which is cleared by veins but leaves behind protein and lipid deposits causing hard exudates (yellowish deposists)
What is the treatment for diabetic retinopathy?
- Early detection and treatment can reduce risk of blindness - Theres a National eye screening program
- Laser therapy, it doesn’t improve sight but stabilises deterioration and prevents progression, but risks include loss of night vision and the loss of peripheral vision
What is diabetic nephropathy?
- Thickening of basement membrane to glomerular damage due to poor glycaemic control leads to microalbuminuria - this gives an early warning sign of an impending renal problem.
- May induce transient nephrotic syndrome
- May progress to end stage kidney disease and require dialysis and transplant
How do you detect diabetic nephropathy?
This is undetectable by conventional dipstick - result shows negative for protein. But urine albumin:creatinine ratio > 3 will indicate microalbuminuria
How do you treat diabetic nephropathy?
Treat BP aggressively with ACE inhibitors or angiotensin receptor blockers
What is the commenest form of diabetic neuropathy?
Commonest form is distal symmetrical neuropathy
What are features of diabetic neuropathy?
- Pain - Allodynia, paraesthesia, burning pain (worse at night)
- Autonomic - Postural hypotension, Gatsroparesis, Diarrhoea, Constipation, Incontinence, Erectile dysfunction
- Insensitivity - ‘Glove and stocking’ sensory loss, can lead to foot ulceration, infection, amputations and falls
- Diabetic amyotrophy - painful asymmetrical wasting of quadriceps, diminished knee reflex
- Mononeuritis - Isolated palsies mainly to extraoccular muscles (III and VI). There’s a characteristic feature of diabetic CN III lesion of sparing of the pupillomotor fibres so there is a retained pupillary reflex
What is the treatment/management for diabetic neuropathy?
Treatment - Good glycaemic control
Management - Foot screening, teach patients to care for feet and check daily
Why are infections more likely in diabetic patients?
Poorly controlled diabetes impairs the function of leucocytes
Define diabetes mellitus Type 1?
Disease of insulin deficiency usually caused by autoimmune destruction of beta cells of the pancreas
What is latent autoimmune diabetes in adults (LADA)?
- A ‘slow burning’ variant with slower progression to insulin deficiency occurs in later life
- May be difficult to differentiate from type 2 diabetes (which also presents in later life) - clinical clues include; leaner build, rapid progression to insulin therapy following an initial response to other therapies and the presence of circulating islet autoantibodies)
What is the aetiology of diabetes T1?
Autoimmune - Auto-antibodies forming against insulin and islet beta cells - Insulitis
Idiopathic
Genetic susceptibility - HLA-DR3-DQ2 or HLA-DR4-DQ8
What is the pathophysiology of diabetes T1?
- Results from autoimmune destruction by autoantibodies of the pancreatic insulin-secreting Beta cells in the Islets of Langerhans
- Causing insulin deficiency and thus the continued breakdown of liver glycogen (producing glucose and ketones) leading to glycosuria and ketonuria as more glucose is in the blood
- In skeletal muscle and fats there is impaired glucose clearance
- Eventual complete Beta cell destruction results in the absence of serum C-peptide
- Present VERY LATE often with only 10% of beta cells remaining
Why are patients with DM T1 present thirsty?
In skeletal muscle and fats there is impaired glucose clearance:
Blood glucose is increased - when it reaches 10mmol/L body can no longer absorb glucose - you become thirsty and get polyuria (as body attempts to remove excess glucose)
Why are patients with DM T2 prone to diabetic ketoacidosis?
- Reduced supply of glucose (since there will be a significant decline in circulating insulin) and an increase in fatty acid oxidation (due to an increase in circulating glucagon)
- The increased production of Acetyl-CoA leads to ketone body production that exceeds the ability of peripheral tissues to oxidise them. Ketone bodies are relatively strong acids (pH 3.5), and their increase lowers the pH of blood
- IMPAIRS THE ABILITY OF HAEMOGLOBIN TO BIND TO OXYGEN - note if a patient is in diabetic ketoacidosis, the excess ketones in the blood will result in their BREATH SMELLING OF PEAR DROPS (KETONES)
What are the risk factors for DM T1?
-Northern European - especially Finnish
-Family history - HLA-DR3-DQ2 or HLA-DR4-DQ8 in > 90%
-Associated with other autoimmune disease:
Autoimmune thyroid
Coeliac disease
Addison’s disease (excess cortisol)
Pernicious anaemia
-Environmental factors:
Dietary constituents
Enteroviruses such as Coxsackie B4
Vitamin D deficiency
Cleaner environment may increase type 1 susceptibility
What is the epidemiology for DM T1?
- Typically manifests in childhood, reaching a peak incidence around the time of puberty - but can present at any age
- Usually younger - < 30yrs
- Patient is usually lean
- Increased in those of Northern European ancestry, especially in Finland
- Incidence is increasing in most populations - particularly children
Define DM T2?
Results from a combination of insulin resistance and less severe insulin deficiency
What is the aetiology of DM T2?
- Decreased insulin secretion +/- increased insulin resistance
- Associated with obesity, lack of exercise, calorie and alcohol excess
- No immune disturbance
- No HLA disturbance but there is a stronger genetic link
- Polygenic disorder
- More common in MALES than females
What conditions is DM T2 associated with?
Central obesity, hypertension, hypertriglyceridaemia, a decreases high-density lipoprotein (HDL) cholesterol, disturbed homeostatic variables and modest increases in a number of pro-inflammatory markers
-accumulation of intracellular triglycerides in muscle and liver and a high proportion have non-alcoholic fatty liver disease
What is the physiology of DM T2?
- Insulin binds normally to its receptor on the surface of cells in DMT2 just like in healthy people - thus insulin resistance develops post-receptor
- At the time of diagnosis the Beta cell mass is reduced to about 50% of normal
- Almost all patient show amyloid deposition in the islets of the pancreas at autopsy derived from a peptide known as amylin or islet amyloid polypeptide which is co-secreted with insulin
- Levels are higher due to increased glucose production from the liver (due to the inadequate suppression of gluconeogenesis) and reduced glucose uptake by peripheral tissues (insulin resistance)
- Hyperglycaemia and lipid excess are toxic to beta cells (glucotoxicity) and this is thought to result in further beta cell loss and further deterioration or glucose homeostasis
- It typically progresses from a preliminary phase of impaired glucose tolerance (IGT) or impaired fasting glucose (IFG) - this is a UNIQUE WINDOW FOR LIFESTYLE INTERVENTION to prevent FULL DMT2 progression
What are the values classifying impaired glucose tolerance?
Fasting plasma glucose < 7mmol/L - Oral glucose tolerance of 2hrs glucose > 7.8mmol/L but < 11mmol/L
What are the values classifying impaired fasting glucose?
Fasting plasma glucose > 6.1mmol/L but < 7mmol/L
What are the risk factors for DMT2?
-Family history - genetics
-Increasing age
-Obesity and poor exercise - can trigger DMT2 in genetically susceptible individuals
-Ethnicity - Middle Eastern, South-east Asian and Western pacific
-Environment:
There is an association between low weight (as a result of poor nutrition) at birth and at 12 months of age with glucose intolerance later in life
Thought to be caused because poor-nutrition early in life impairs beta cell development and function - predisposing to diabetes later in life
Low birth weight has also been shown to predispose to heart disease and hypertension
What is the epidemiology of DM T2?
- Common is all populations enjoying an affluent lifestyle - has increased in incidence due to the ageing population and increasing obesity in the Western world
- Older - usually >30 yrs of age - but teenagers are starting to get it
- Often overweight around the abdomen
- More prevalent in South Asian, African and Caribbean ancestry
- Middle eastern and Hispanic Americans also more at risk
- Hypertension is present in 50% of patients with DMT2 and a higher proportion of African and Caribbean patients
What is the difference in presentation of DMT1 and DMT2?
- type 1 tend to be leaner and present with more marked polydipsia, polyuria, weight loss and ketosis
- type 2 the patient tends to be overweight in the abdominal area and also presents with polydipsia, polyuria and weight loss and ketosis (only when very advanced with absolute insulin deficiency) but less marked
Signs of diabetes mellitus?
-Ketonuria is often present in young people and may progress to ketoacidosis if these early symptoms are not recognised and treated:
Occur primarily in DMT1 and very advanced DMT2 (i.e. when there is absolute insulin deficiency)
-Patients may have breath smelling of ketones (pear-drops)
-Evidence of weight loss and dehydration may be present
-Older patients may present with established complications and the presence of the characteristic retinopathy is DIAGNOSTIC in diabetes
-Patients with severe insulin resistance (i.e. DMT2) may have acanthosis nigricans - characterised by blackish pigmentation at the nape of the neck and in the axillae
What is the classic triad of symptoms for a patient with DMT1?
2-6week history
-Polyuria and nocturia:
Since glucose draws water into the urine by osmosis - not enough glucose can be reabsorbed as kidneys have reached the renal maximum reabsorptive capacity
This results in high levels of glucose in tubule urine and thus lots of water resulting in polyuria and nocturia
-Polydipsia (thirst):
Due to the loss of fluid and electrolytes from excess glucose and thus water being in the urine
-Weight loss:
Due to fluid depletion and the accelerated breakdown of fat and muscle secondary to insulin deficiency
What are the symptoms of subacute presentation (months-years) of DM?
- Onset may be over several months or years, particularly in older patients
- Polyuria, polydipsia and weight loss are typically present but tend to be less marked
- Patients may complain of such symptoms as lack of energy, visual blurring (due to glucose-induce changes in refraction) or pruritus vulvae or balantis that is due to Candida infection
What do you look for in asyptomatic patients with DM?
- In these individuals, the only symptoms detected may just by glycosuria and raised blood glucose with no other symptoms of ill-health
- More common in older people, who have a raised renal threshold for glucose
- When present, glycosuria is NOT DIAGNOSTIC for diabetes but indicates the need for further investigations
What investigations are undertaken for patients with suspected DM?
-Random plasma glucose
-Fasting plasma glucose
For both tests one abnormal value is DIAGNOSTIC in symptomatic individuals
Two abnormal values are required in asymptomatic individuals
For borderline cases:
-Oral glucose tolerance tests (OGTT)
-Haemoglobin A1c:
-Screen urine for microalbuminuria - to asses for kidney disease
FBC, U&Es, liver biochemistry, fasting blood sample for cholesterol and triglycerides
Raised blood pH to look for metabolic acidosis (high H+ and low HCO3-, due to ketoacidosis) - seen in DMT1 and advanced DMT2
What values indication diabetes diagnosis in oral glucose tolerance test?
-Fasting > 7mmol/L = DIABETES DIAGNOSIS
-2 hrs after glucose > 11.1 mmol/L = DIABETES DIAGNOSIS
-Can also detect impaired glucose tolerance (IGT) - a risk factor for future diabetes and cardiovascular disease:
Fasting < 7mmol/L
2 hrs after glucose 7.8-11.0mmol/L
What values indication diabetes diagnosis in HbA1c?
- Measures amount of glycated haemoglobin - thus tells us blood glucose concentration
- HbA1c > 6.5% normal (48mmol/mol) = DIABETES DIAGNOSIS
What values indication diabetes diagnosis in random plasma glucose?
> 11.1mmol/L = DIABETES DIAGNOSIS
What values indication diabetes diagnosis in fasting plasma glucose?
> 7mmol/L = DIABETES DIAGNOSIS
What are complication of DM?
- Staphylococcal skin infection
- Retinopathy found during visit to optician
- Polyneuropathy causing tingling and numbness in the feet
- Erectile dysfunction
- Arterial disease resulting in MI or peripheral gangrene
What are non-pharmacological treatment/management of both DMT1 and DMT2?
-MDT approach
-Educate patient on disease and risks
-Maintain lean weight, stop smoking and take care of feet (to reduce gangrene risk)
-Encourage regular physical activity and reduction in bodyweight in the obese - both of which improve glycaemic control in DMT2
-Good glycemic control with good diet:
Low in sugar
High in starchy carbohydrates with low glycaemic index e.g. pasta
High in fibre
Low in fat
What are pharmacological treatment/management of both DMT1 and DMT2?
- Treatment of hypertension with ACE-inhibitors e.g. RAMIPRIL
- Treatment of hyperlipidaemia with statins e.g. SIMVASTATIN - risk factors for long term complication
What are pharmacological treatment/management of DMT1?
-Insulin is always indicated in a patient who has been in ketoacidosis and is usually required in lean patients who present under the age of 40
-For good control is it VITAL to educate to self-adjust doses
-Ensure they:
Can phone for support (24/7 nurse)
Can modify diet wisely and avoid binge drinking
Partner can abort hypoglycaemia e.g. sugary drinks
-Synthetic (recombinant) human insulin is used and administered via SUBCUTANEOUS INJECTION into abdomen, thighs or upper arm
-Change injection site to prevent areas of lipohypertrophy (fatty lumps)